SPINOGENIX: FDA MEETING PROVIDED A CLEAR PATH FORWARD ON DESIGN OF A TRIAL TO ASSESS SAFETY, EFFICACY OF SPG601 IN PATIENTS WITH FXS

Reuters · 09/02/2025 12:32

Please log in to view news